Spooked AbbVie investors are selling off shares—but should they? by Carly Helfand Friday, July 20, 2018 AbbVie investors are running for the exits. But they don’t need to be, industry watchers say.
Grocers take on generic drug industry in price-fixing suit by Eric Sagonowsky Wednesday, January 31, 2018 Kroger and other grocery chains are suing Mylan, Teva, Endo and many other companies for an "overarching conspiracy" to artificially inflate prices.
Former Valeant, Philidor execs plead not guilty to fraud charges by Carly Helfand Friday, February 24, 2017 The former Valeant and Philidor execs accused of engineering a multimillion-dollar fraud and kickback scheme say they didn’t do it.
Short seller sics Trump on Express Scripts; shares drop by Tracy Staton Thursday, December 8, 2016 Short seller Andrew Left sent Express Scripts shares reeling Thursday afternoon by invoking the wrath of President-elect Donald Trump.
Short-seller Andrew Left levels new charges at Mallinckrodt by Tracy Staton Wednesday, May 18, 2016 Mallinckrodt has faced plenty of criticism about H.P. Acthar Gel, what with pricing controversies, federal probes and basic questions about its efficacy. Now, short-seller Andrew Left has issued a new challenge.
